Advanced Nanomaterials to Target Genomic and Z-DNA for Bacterial Biofilm Eradication
Fighting Superbugs with a New Scientific Breakthrough
Why This Matters
Antibiotic resistance—when bacteria stop responding to medicines—has become one of the biggest global health problems. These “superbugs” make infections harder to treat and can lead to longer hospital stays, complications, and even death.
A big part of the problem is biofilms—slimy layers that bacteria create to protect themselves. These make hard to get rid of infections and help bacteria survive even strong antibiotics.
The World Health Organization (WHO) has warned that antibiotic resistance is one of the top 10 threats to global health.
What BactEradiX Will Do
BactEradiX will develop tiny, advanced materials (called nanomaterials) designed to break through these biofilms and kill the resistant bacteria hiding inside. These new treatments will focus on two of the most dangerous bacteria:
- Staphylococcus aureus (a type of staph infection resistant to many antibiotics such as methicillin)
- Pseudomonas aeruginosa (resistant to many drugs, and a common cause of lung and wound infections)
The team is creating a flexible and targeted way to fight these bacteria using cutting-edge science and nanotechnology.
What This Could Mean for the Future
BactEradiX aims to:
- Help doctors treat infections that no longer respond to antibiotics
- Lower healthcare costs by reducing treatment failures
- Improve the lives of patients around the world
With its bold approach, BactEradiX hopes to make a real difference in the fight against antibiotic resistance.
Stay in the loop:
Visit www.bacteradix.eu or follow us on LinkedIn for updates!